Jim Cramer - Mad Money Jazz Pharmaceuticals JAZZ-Q COMMENT Apr 24, 2023

They overspent on a recent acquisition. He's not panicking, because long-term this will be fine.

Jim Cramer - Mad Money

Unknown

Unlock Rating

$144.480

Stock price when the opinion was issued

Pharma & Healthcare

It's the ideal tool to help you make quicker, more informed decisions for managing and tracking your investments.

Get Signals Create your Watchlist

You might be interested:

PARTIAL BUY

A great growth company, but it will keep selling off. Buy a little now then wait for a 10% move to buy more.

Most Recent Experts

Larry Berman CFA, CMT, CTA

ETF Capital Management Inc.

Greg Dean

Cambridge Global Asset Management

Stockchase Insights

5i Research

Jim Cramer - Mad Money

CNBC

Colin Stewart

JC Clark Investments Ltd.

Stockchase, in its reporting on what has been discussed by individuals on business television programs (in particular Business News Network), neither recommends nor promotes any investment strategies.

We paraphrase the experts by hand, we watch the shows and write down what we understood from the experts’ comments. We are human and can make mistakes, help us fix any errors. If you see something that you know is not right or if there is a problem with the site, feel free to email us at : hello@stockchase.com.

Jim Cramer - Mad Money Jazz Pharmaceuticals JAZZ-Q COMMENT Apr 24, 2023

You might be interested:

Jazz Pharmaceuticals(JAZZ-Q)

Latest Buy Signals

Today's Top Picks

Popular Articles

Latest Sell Signals

Most Recent Experts

Larry Berman CFA, CMT, CTA

Greg Dean

Stockchase Insights

Jim Cramer - Mad Money

Colin Stewart